The usefulness of phosphorylated-signal transduction and activators of transcription 3 in detecting prostate cancer from negative biopsies

European Journal of Surgical Oncology

Volumn 38, Issue 4, 2012, Pages 367-373

  Han, G ^a,b   Yu, J Y ^c   Chen, Y D ^a   Cao, X L ^b   Zhu, J ^b   Wang, W ^b   Wang, X X ^b   Zhang, X ^b   Yan, J Q ^c   Gao, J P ^b,d  

^a The 252 Hospital of Chinese PLA   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^d CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Biopsy; Diagnosis; Immunohistochemistry; Prostate specific antigen; Prostatic neoplasms

Indexed keywords

STAT3 PROTEIN; TUMOR MARKER;

ADULT; AGED; ANTIBODY LABELING; AREA UNDER THE CURVE; ARTICLE; BENIGN TUMOR; CANCER DIAGNOSIS; CANCER LOCALIZATION; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; TUMOR BIOPSY;

AGED; AGED, 80 AND OVER; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PHOSPHORYLATION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSTATIC NEOPLASMS; ROC CURVE; SENSITIVITY AND SPECIFICITY; STAT3 TRANSCRIPTION FACTOR; TUMOR MARKERS, BIOLOGICAL;

EID: 84862812077     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2012.01.003     Document Type: Article

References (20)

1. T.J. Polascik, J.E. Oesterling, and A.W. Partin Prostate specific antigen: a decade of discovery-what we have learned and where we are going J Urol 162 2 1999 293 306 (Pubitemid 29434327)
2. J.C. Applewhite, B.R. Matlaga, and D.L. McCullough Results of the 5 region prostate biopsy method: the repeat biopsy population J Urol 168 2 2002 500 503 (Pubitemid 34793281)
3. Y.M. Hong, F.C. Lai, C.H. Chon, J.E. McNeal, and J.C. Presti Jr. Impact of prior biopsy scheme on pathologic features of cancers detected on repeat biopsies Urol Oncol 22 1 2004 7 10 (Pubitemid 38542705)
4. C. Schindler, and J.E. Darnell Jr. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway Annu Rev Biochem 64 1995 621 651
5. J.E. Darnell Jr. STATs and gene regulation Science 277 5332 1997 1630 1635 (Pubitemid 27446219)
6. V. Gouilleux-Gruart, F. Gouilleux, and C. Desaint STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients Blood 87 5 1996 1692 1697 (Pubitemid 26068885)
7. C.J. Watson, and W.R. Miller Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts Br J Cancer 71 4 1995 840 844
8. J.R. Grandis, S.D. Drenning, and Q. Zeng Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo Proc Natl Acad Sci U S A 97 8 2000 4227 4232 (Pubitemid 30226115)
9. R. Dhir, Z. Ni, W. Lou, F. DeMiguel, J.R. Grandis, and A.C. Gao Stat3 activation in prostatic carcinomas Prostate 51 4 2002 241 246 (Pubitemid 34556374)
10. X. Hao, I. Tomlinson, M. Ilyas, J.P. Palazzo, and I.C. Talbot Reciprocity between membranous and nuclear expression of beta-catenin in colorectal tumours Virchows Arch 431 3 1997 167 172 (Pubitemid 27440360)
11. K.K. Hodge, J.E. McNeal, M.K. Terris, and T.A. Stamey Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate J Urol 142 1 1989 71 74
12. I.M. Thompson, D.P. Ankerst, and C. Chi Assessing prostate cancer risk: results from the prostate cancer prevention trial J Natl Cancer Inst 98 8 2006 529 534 (Pubitemid 43898816)
13. B. Djavan, Y.K. Fong, and V. Ravery Are repeat biopsies required in men with PSA levels < or =4 ng/ml? A Multiinstitutional Prospective European Study Eur Urol 47 1 2005 38 44 (Pubitemid 39575716)
14. A. Heidenreich, J. Bellmunt, and M. Bolla EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease Eur Urol 59 1 2011 61 71
15. A.K.M. Shamsuddin, L. Weiss, P.C. Phelps, and B.F. Trump Colon epithelium. IV. Human colon carcinogenesis. Changes in human colon mucosa adjacent to and remote from carcinomas of the colon JNCI 66 1981 413 419 (Pubitemid 11117648)
16. A.G. Montag, P. Bartels, H.E. Dytch, E. Lerma-Puertas, F. Michelassi, and M. Bibbo Karyometric marker features in tissue adjacent to in situ cervical carcinoma Anal Quant Cytol Histol 11 1989 275 280 (Pubitemid 20122542)
17. C. MacAulay, S. Lam, P.W. Payne, J.C. LeRiche, and B. Palcic Malignancyassociated changes in bronchial epithelial cells in biopsy specimens Anal Quant Cytol Histol 17 1995 55 61
18. A.G. Montag, P.H. Bartels, H.E. Dytch, E. Lerma-Puertas, F. Michelassi, and M. Bibbo Karyometric features in nuclei near colonic adenocarcinoma. Statistical analysis Anal Quant Cytol Histol 13 1991 159 167
19. M. Slater, S. Danieletto, A. Gidley-Baird, L.C. Teh, and J.A. Barden Early prostate cancer detected using expression of non-functional cytolytic P2X7 receptors Histopathology 44 3 2004 206 215 (Pubitemid 38406612)
20. R. Dhir, B. Vietmeier, and J. Arlotti Early identification of individuals with prostate cancer in negative biopsies J Urol 171 4 2004 1419 1423 (Pubitemid 38365385)